{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:05:12Z","timestamp":1790888712242,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100010526","name":"NHS Greater Glasgow and Clyde","doi-asserted-by":"publisher","award":["Pharmacy Services Research Catalytic Funding Challenge Award Number 9"],"award-info":[{"award-number":["Pharmacy Services Research Catalytic Funding Challenge Award Number 9"]}],"id":[{"id":"10.13039\/100010526","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11096-025-01938-8","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:04:20Z","timestamp":1749009860000},"page":"1395-1405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluating a pharmacist-led cardio-renal-metabolic service to reduce healthcare inequities in a socioeconomically deprived population: a prospective intervention study"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8055-6502","authenticated-orcid":false,"given":"Tania","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6606-809X","authenticated-orcid":false,"given":"Iain","family":"Speirits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"McInally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4963-5870","authenticated-orcid":false,"given":"Brian","family":"Kennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3804-6795","authenticated-orcid":false,"given":"Paul","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lowrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-6605","authenticated-orcid":false,"given":"Chris F.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"1938_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20:473\u201385.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"1938_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","volume":"14","author":"HJ Anders","year":"2018","unstructured":"Anders HJ, Huber TB, Isermann B, et al. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14(6):361\u201377.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"1938_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrneph.2015.173","volume":"12","author":"MC Thomas","year":"2016","unstructured":"Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73\u201381.","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"1938_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","volume":"18","author":"K Matsushita","year":"2022","unstructured":"Matsushita K, Ballew SH, Wang AY, et al. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18(11):696\u2013707.","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"1938_CR5","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1007\/s12325-023-02608-9","volume":"40","author":"V Jha","year":"2023","unstructured":"Jha V, Al-Ghamdi SMG, Li G, et al. Global economic burden associated with chronic kidney disease: a pragmatic review of medical costs for the inside CKD research programme. Adv Ther. 2023;40(10):4405\u201320.","journal-title":"Adv Ther"},{"key":"1938_CR6","unstructured":"Farrimond B, Agathangelou G, Gofman L, et al. Kidney research UK. Kidney disease: a UK public health emergency. The health economics of kidney disease to 2033. 2023. https:\/\/www.kidneyresearchuk.org\/wp-content\/uploads\/2023\/06\/Economics-of-Kidney-Disease-full-report_accessible.pdf. Accessed 30 Apr 2025."},{"issue":"7","key":"1938_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/jech.57.7.523","volume":"57","author":"R Maheswaran","year":"2003","unstructured":"Maheswaran R, Payne N, Meechan D, et al. Socioeconomic deprivation, travel distance, and renal replacement therapy in the Trent Region, United Kingdom 2000: an ecological study. J Epidemiol Community Health. 2003;57(7):523\u20134.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"1938_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","volume":"80","author":"AS Levey","year":"2011","unstructured":"Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80(1):17\u201328.","journal-title":"Kidney Int"},{"issue":"6","key":"1938_CR9","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1053\/j.ajkd.2013.12.008","volume":"63","author":"M Sud","year":"2014","unstructured":"Sud M, Tangri N, Levin A, et al. CKD stage at nephrology referral and factors influencing the risks of ESRD and death. Am J Kidney Dis. 2014;63(6):928\u201336.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"1938_CR10","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1681\/ASN.2014070714","volume":"26","author":"S Thompson","year":"2015","unstructured":"Thompson S, James M, Wiebe N, et al. Cause of death in patients with reduced kidney function. J Am Soc Nephrol. 2015;26(10):2504\u201311.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1938_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11886-019-1107-y","volume":"21","author":"D Glovaci","year":"2019","unstructured":"Glovaci D, Fan W, Wong ND. Epidemiology of diabetes mellitus and cardiovascular disease. Curr Cardiol Rep. 2019;21(4):21.","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"1938_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","volume":"22","author":"M Marassi","year":"2023","unstructured":"Marassi M, Fadini GP. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol. 2023;22(1):195.","journal-title":"Cardiovasc Diabetol"},{"key":"1938_CR13","unstructured":"British Heart Foundation. Scotland cardiovascular disease factsheet. 2023. https:\/\/www.bhf.org.uk\/-\/media\/files\/for-professionals\/research\/heart-statistics\/bhf-cvd-statistics-scotland-factsheet.pdf. Accessed 30 Apr 2025."},{"issue":"9836","key":"1938_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37\u201343.","journal-title":"Lancet"},{"issue":"677","key":"1938_CR15","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3399\/bjgp18X699893","volume":"68","author":"G Watt","year":"2018","unstructured":"Watt G. The inverse care law revisited: a continuing blot on the record of the National Health Service. Br J Gen Pract. 2018;68(677):562\u20133.","journal-title":"Br J Gen Pract"},{"issue":"7696","key":"1938_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0140-6736(71)92410-X","volume":"1","author":"JT Hart","year":"1971","unstructured":"Hart JT. The inverse care law. Lancet. 1971;1(7696):405\u201312.","journal-title":"Lancet"},{"issue":"643","key":"1938_CR17","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.3399\/bjgp16X683425","volume":"66","author":"N Doran","year":"2016","unstructured":"Doran N, Fox F, Rodham K, et al. Lost to the NHS: a mixed methods study of why GPs leave practice early in England. Br J Gen Pract. 2016;66(643):e128\u201335.","journal-title":"Br J Gen Pract"},{"issue":"7","key":"1938_CR18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/bmjqs-2022-015353","volume":"32","author":"R Parisi","year":"2023","unstructured":"Parisi R, Lau Y-S, Bower P, et al. Predictors and population health outcomes of persistent high GP turnover in English general practices: a retrospective observational study. BMJ Qual Saf. 2023;32(7):394\u2013403.","journal-title":"BMJ Qual Saf"},{"issue":"15","key":"1938_CR19","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1136\/heartjnl-2015-307516","volume":"101","author":"P Bhatnagar","year":"2015","unstructured":"Bhatnagar P, Wickramasinghe K, Williams J, et al. The epidemiology of cardiovascular disease in the UK 2014. Heart. 2015;101(15):1182\u20139.","journal-title":"Heart"},{"key":"1938_CR20","unstructured":"Calderwood C. Realising realistic medicine: Chief Medical Officer's annual report 2015\u201316. 2017. https:\/\/www.gov.scot\/publications\/chief-medical-officer-scotland-annual-report-2015-16-realising-realistic-9781786526731\/. Accessed 30 Apr 2025."},{"issue":"1","key":"1938_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12875-020-01197-8","volume":"21","author":"RA Damarell","year":"2020","unstructured":"Damarell RA, Morgan DD, Tieman JJ. General practitioner strategies for managing patients with multimorbidity: a systematic review and thematic synthesis of qualitative research. BMC Fam Pract. 2020;21(1):131.","journal-title":"BMC Fam Pract"},{"issue":"4","key":"1938_CR22","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.sapharm.2013.08.006","volume":"10","author":"EC Tan","year":"2014","unstructured":"Tan EC, Stewart K, Elliott RA, et al. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Soc Adm Pharm. 2014;10(4):608\u201322.","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"1938_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41533-018-0105-7","volume":"28","author":"V Hunt","year":"2018","unstructured":"Hunt V, Anderson D, Lowrie R, et al. A non-randomised controlled pilot study of clinical pharmacist collaborative intervention for community dwelling patients with COPD. NPJ Prim Care Respir Med. 2018;28(1):38.","journal-title":"NPJ Prim Care Respir Med"},{"issue":"4","key":"1938_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/fampra\/cmab175","volume":"39","author":"CF Johnson","year":"2022","unstructured":"Johnson CF, Maskrey M, Macbride-Stewart S, et al. New ways of working releasing general practitioner capacity with pharmacy prescribing support: a cost-consequence analysis. Fam Pract. 2022;39(4):648\u201355.","journal-title":"Fam Pract"},{"key":"1938_CR25","unstructured":"Clarke G. Pharmaceutical Society of Australia (PSA) release pharmacist prescribing position statement. 2024. https:\/\/www.psa.org.au\/psa-release-pharmacist-prescribing-position-statement\/#:~:text=PSA%20National%20President%20Associate%20Professor,to%20medicines%2C%20not%20limit%20it.&text=%E2%80%9CPharmacists%20should%20not%20be%20prevented,within%20their%20scope%20of%20practice. Accessed 30 Apr 2025."},{"issue":"1","key":"1938_CR26","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1186\/s12913-023-09877-8","volume":"23","author":"K Norman","year":"2023","unstructured":"Norman K, Cassim S, Papa V, et al. \u201cPrescribing for the whole person\u201d: a qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand. BMC Health Serv Res. 2023;23(1):1058.","journal-title":"BMC Health Serv Res"},{"key":"1938_CR27","unstructured":"The Scottish Government. The 2018 general medical services contract in Scotland. 2017. https:\/\/www.gov.scot\/binaries\/content\/documents\/govscot\/publications\/advice-and-guidance\/2017\/11\/2018-gms-contract-scotland\/documents\/00527530-pdf\/00527530-pdf\/govscot%3Adocument\/00527530.pdf. Accessed 30 Apr 2025."},{"key":"1938_CR28","unstructured":"NHS England. More than 400 pharmacists to be recruited to GP surgeries by next year. 2015. https:\/\/www.england.nhs.uk\/2015\/11\/pharmacists-recruited\/. Accessed 30 Apr 2025."},{"key":"1938_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348: g1687.","journal-title":"BMJ"},{"issue":"3","key":"1938_CR30","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","volume":"99","author":"AK Cheung","year":"2021","unstructured":"Cheung AK, Chang TI, Cushman WC, et al. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3):S1\u201387.","journal-title":"Kidney Int"},{"key":"1938_CR31","unstructured":"Sign 154. Pharmacological management of glycaemic control in people with type 2 diabetes. 2017. https:\/\/www.sign.ac.uk\/media\/1090\/sign154.pdf. Accessed 30 Apr 2025."},{"key":"1938_CR32","unstructured":"NICE 203\u2014chronic kidney disease: assessment and management. 2021. https:\/\/www.nice.org.uk\/guidance\/ng203\/resources\/chronic-kidney-disease-assessment-and-management-pdf-66143713055173. Accessed 30 Apr 2025."},{"key":"1938_CR33","unstructured":"McQuarrie E. Chronic kidney disease, adult: diagnosis and management (1087). 2023. https:\/\/rightdecisions.scot.nhs.uk\/media\/2735\/1087-adult-chronic-kidney-disease.pdf. Accessed 30 Apr 2025."},{"key":"1938_CR34","unstructured":"Byrne J. Coronary heart disease and stroke, primary and secondary prevention guideline (cholesterol). 2022. https:\/\/rightdecisions.scot.nhs.uk\/ggc-clinical-guideline-platform\/endocrine\/co-morbidities\/coronary-heart-disease-and-stroke-primary-and-secondary-prevention-cholesterol-181\/. Accessed 30 Apr 2025."},{"issue":"1","key":"1938_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"Eur Heart J"},{"key":"1938_CR36","unstructured":"Scottish Government. Scottish Government Polypharmacy Model of Care Group. Polypharmacy guidance, realistic prescribing. 3rd ed. 2018. https:\/\/www.therapeutics.scot.nhs.uk\/wp-content\/uploads\/2018\/04\/Polypharmacy-Guidance-2018.pdf. Accessed 30 Apr 2025."},{"key":"1938_CR37","unstructured":"Polypharmacy review in adults living with moderate to severe frailty. 2022. https:\/\/rightdecisions.scot.nhs.uk\/media\/2276\/polypharmacy-review.pdf. Accessed 30 Apr 2025."},{"key":"1938_CR38","unstructured":"Quality Prescribing Strategy for Type 2 Diabetes Mellitus. A guide for improvement 2024\u20132027. 2024. https:\/\/www.gov.scot\/binaries\/content\/documents\/govscot\/publications\/advice-and-guidance\/2024\/01\/quality-prescribing-strategy-type-2-diabetes-mellitus-guide-improvement-2024-2027\/documents\/quality-prescribing-strategy-type-2-diabetes-mellitus-guide-improvement-2024-2027\/quality-prescribing-strategy-type-2-diabetes-mellitus-guide-improvement-2024-2027\/govscot%3Adocument\/quality-prescribing-strategy-type-2-diabetes-mellitus-guide-improvement-2024-2027.pdf. Accessed 30 Apr 2025."},{"key":"1938_CR39","unstructured":"Kidney Care UK. Patient information booklets. https:\/\/kidneycareuk.org\/get-support\/free-resources\/patient-information-booklets\/. Accessed 30 Apr 2025."},{"issue":"11","key":"1938_CR40","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s40266-018-0593-8","volume":"35","author":"LK Triantafylidis","year":"2018","unstructured":"Triantafylidis LK, Hawley CE, Perry LP, et al. The role of deprescribing in older adults with chronic kidney disease. Drugs Aging. 2018;35(11):973\u201384.","journal-title":"Drugs Aging"},{"key":"1938_CR41","unstructured":"Brady A. Hypertension management, heart managed clinical network. Greater Glasgow and Clyde clinical guidelines 2020. https:\/\/clinicalguidelines.nhsggc.org.uk\/media\/1964\/hypertension-management-heart-mcn.pdf. Accessed 30 Apr 2025."},{"issue":"6","key":"1938_CR42","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/ndt\/gfu408","volume":"30","author":"BH So","year":"2015","unstructured":"So BH, Methven S, Hair MD, et al. Socio-economic status influences chronic kidney disease prevalence in primary care: a community-based cross-sectional analysis. Nephrol Dial Transplant. 2015;30(6):1010\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"1938_CR43","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure service. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"704","key":"1938_CR44","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.3399\/bjgp20X714125","volume":"71","author":"C MacRae","year":"2021","unstructured":"MacRae C, Mercer SW, Guthrie B, et al. Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care. Br J Gen Pract. 2021;71(704):e243\u20139.","journal-title":"Br J Gen Pract"},{"issue":"15","key":"1938_CR45","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436\u201346.","journal-title":"N Engl J Med"},{"issue":"1","key":"1938_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/fampra\/cmad120","volume":"41","author":"CF Johnson","year":"2024","unstructured":"Johnson CF, Ingram F, Thomson F, et al. General practice pharmacist-led antipsychotic physical health monitoring: a prospective intervention scoping study. Fam Pract. 2024;41(1):41\u20139.","journal-title":"Fam Pract"},{"issue":"1","key":"1938_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1192\/bjb.2019.42","volume":"44","author":"CF Johnson","year":"2020","unstructured":"Johnson CF, Liddell K, Guerri C, et al. Medicines reconciliation at the community mental health team\u2013general practice interface: quality improvement study. BJPsych Bull. 2020;44(1):12\u20138.","journal-title":"BJPsych Bull"},{"issue":"9328","key":"1938_CR48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0140-6736(02)09466-7","volume":"360","author":"G Watt","year":"2002","unstructured":"Watt G. The inverse care law today. Lancet. 2002;360(9328):252\u20134.","journal-title":"Lancet"},{"issue":"3","key":"1938_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/ijpp\/riaa016","volume":"29","author":"C Clarke","year":"2021","unstructured":"Clarke C, Tennant S, Greenlaw N, et al. The cardiology training needs of general practice-based pharmacists. Int J Pharm Pract. 2021;29(3):245\u201351.","journal-title":"Int J Pharm Pract"},{"key":"1938_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183: 109119.","journal-title":"Diabetes Res Clin Pract"},{"key":"1938_CR51","unstructured":"Bell S, Marjoribanks S. Public Health Scotland. Scottish renal registry annual report 2023. A management information release for Scotland. 2023. https:\/\/publichealthscotland.scot\/publications\/scottish-renal-registry\/scottish-renal-registry-annual-report-2023\/. Accessed 30 Apr 2025."},{"issue":"10225","key":"1938_CR52","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"issue":"4","key":"1938_CR53","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/ki.2015.228","volume":"88","author":"M Tonelli","year":"2015","unstructured":"Tonelli M, Wiebe N, Guthrie B, et al. Comorbidity as a driver of adverse outcomes in people with chronic kidney disease. Kidney Int. 2015;88(4):859\u201366.","journal-title":"Kidney Int"},{"issue":"2","key":"1938_CR54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/qjmed\/hcr153","volume":"105","author":"MP Hossain","year":"2012","unstructured":"Hossain MP, Palmer D, Goyder E, et al. Social deprivation and prevalence of chronic kidney disease in the UK: workload implications for primary care. QJM Int J Med. 2012;105(2):167\u201375.","journal-title":"QJM Int J Med"},{"issue":"1","key":"1938_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/bcp.14164","volume":"86","author":"AA Alshehri","year":"2020","unstructured":"Alshehri AA, Jalal Z, Cheema E, et al. Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: a systematic review and meta-analysis of randomised controlled trials. Br J Clin Pharmacol. 2020;86(1):29\u201338.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1938_CR56","first-page":"45","volume":"28","author":"J George","year":"2006","unstructured":"George J, Pfleger D, McCaig D, et al. Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists. Int J Clin Pharm. 2006;28(2):45\u201353.","journal-title":"Int J Clin Pharm"},{"key":"1938_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12882-015-0052-2","volume":"16","author":"D Cooney","year":"2015","unstructured":"Cooney D, Moon H, Liu Y, et al. A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial. BMC Nephrol. 2015;16:56.","journal-title":"BMC Nephrol"},{"key":"1938_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-072098","volume":"380","author":"DR Morales","year":"2023","unstructured":"Morales DR, Minchin M, Kontopantelis E, et al. Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland: controlled interrupted time series analysis. Br Med J. 2023;380: e072098.","journal-title":"Br Med J"},{"issue":"700","key":"1938_CR59","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.3399\/bjgp20X713105","volume":"70","author":"M Molokhia","year":"2020","unstructured":"Molokhia M, Okoli GN, Redmond P, et al. Uncoded chronic kidney disease in primary care: a cross-sectional study of inequalities and cardiovascular disease risk management. Br J Gen Pract. 2020;70(700):e785\u201392.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"1938_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3399\/BJGPO.2023.0079","volume":"8","author":"R Sisk","year":"2024","unstructured":"Sisk R, Cameron R, Tahir W, et al. Diagnosis codes underestimate chronic kidney disease incidence compared with eGFR-based evidence: a retrospective observational study of patients with type 2 diabetes in UK primary care. Br J Gen Pract Open. 2024;8(1):1\u201310.","journal-title":"Br J Gen Pract Open"},{"issue":"1","key":"1938_CR61","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.sapharm.2022.08.016","volume":"19","author":"P Forsyth","year":"2023","unstructured":"Forsyth P, Radley A, Rushworth GF, et al. The collaborative care model: realizing healthcare values and increasing responsiveness in the pharmacy workforce. Res Soc Adm Pharm. 2023;19(1):110\u201322.","journal-title":"Res Soc Adm Pharm"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01938-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-01938-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01938-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T10:02:54Z","timestamp":1757671374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-01938-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1938"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-01938-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6209460\/v1","asserted-by":"object"}]},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}